A detailed history of Sivia Capital Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sivia Capital Partners, LLC holds 4,493 shares of ABBV stock, worth $788,880. This represents 0.52% of its overall portfolio holdings.

Number of Shares
4,493
Previous 4,395 2.23%
Holding current value
$788,880
Previous $754 Million 17.7%
% of portfolio
0.52%
Previous 0.5%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$163.84 - $199.33 $16,056 - $19,534
98 Added 2.23%
4,493 $887 Million
Q2 2024

Aug 05, 2024

BUY
$154.79 - $180.76 $27,397 - $31,994
177 Added 4.2%
4,395 $754 Million
Q1 2024

Apr 18, 2024

BUY
$159.82 - $182.1 $84,544 - $96,330
529 Added 14.34%
4,218 $768 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $507,606 - $571,684
3,689 New
3,689 $572 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sivia Capital Partners, LLC Portfolio

Follow Sivia Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivia Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivia Capital Partners, LLC with notifications on news.